A matched-control comparison of serious adverse events after intravitreal injections of bevacizumab for age-related macular degeneration and cataract extraction

PURPOSE: The study reported here investigated the rates of systemic serious adverse events (SAEs) following treatment with intravitreal bevacizumab for age-related macular degeneration (AMD) in comparison with a matched control group. METHODS: A retrospective age- and sex-matched case-control design...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Fischer, Naomi, Moisseiev, Elad, Waisbourd, Michael, Goldstein, Michaella, Loewenstein, Anat
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2013
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3615876/
https://ncbi.nlm.nih.gov/pubmed/23569355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S42881
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller